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Background. Functional brain abnormalities have been repeatedly demonstrated in schizophrenia but there is little
data concerning their progression. For such studies to have credibility it is first important to establish the
reproducibility of functional imaging techniques. The current study aimed to examine these factors in healthy
controls and in unmedicated subjects at high genetic risk of the disorder : (i) to examine the reproducibility of task-
related activation patterns, (ii) to determine if there were any progressive functional changes in high-risk subjects
versus controls reflecting inheritance of the schizophrenic trait, and (iii) to examine changes over time in relation to
fluctuating positive psychotic symptoms (i.e. state effects).
Method. Subjects were scanned performing the Hayling sentence completion test on two occasions 18 months
apart. Changes in activation were examined in controls and high-risk subjects (n=16, n=63). Reproducibility was
assessed for controls and high-risk subjects who remained asymptomatic at both time points (n=16, n=32).
Results. Intra-class correlation values indicated good agreement between scanning sessions. No significant
differences over time were seen between the high-risk and control group ; however, comparison of high-risk subjects
who developed symptoms versus those who remained asymptomatic revealed activation increases in the left middle
temporal gyrus (p=0.026).
Conclusions. The current results suggest that functional changes over time occur in the lateral temporal cortex as
high genetic risk subjects become symptomatic, further, they indicate the usefulness of functional imaging tools for
investigating progressive changes associated with state and trait effects in schizophrenia.
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Introduction
Although it is well established that patients with
schizophrenia have demonstrable structural and func-
tional brain abnormalities in prefrontal and temporal
regions, much less is known about brain changes over
time in association with the disorder (Shenton et al.
2001 ; Fusar-Poli et al. 2007). This issue has central im-
portance with regard to understanding the nature
of the disease, in terms of whether abnormalities are
neurodevelopmental in origin, whether they are pro-
gressive, or a combination of the two. Indeed, the lack
of unequivocal evidence for clinical or biological pro-
gression in the established condition could infer that
the period of greatest change occurs prior to develop-
ment of the disorder and could relate to inheritance of
the schizophrenic trait, or alternatively may reflect
subtle changes in association with evolving symp-
tomatology. Hence, there is interest in studying the
relationship between functional brain abnormalities
and the course and early symptoms of the disorder.
There is a paucity of data tracking the progression
of functional abnormalities in high-risk populations.
Longitudinal functional magnetic resonance imaging
(fMRI) studies have, however, previously been con-
ducted in patients with established schizophrenia and
other clinical populations as well as in healthy control
subjects, indicating the feasibility of the technique to
examine changes in brain function (Ward et al. 2003 ;
Tombari et al. 2004 ; Yoo et al. 2005 ; Szaflarski et al.
2006 ; Marchand et al. 2007). There is also a growing
body of literature directly addressing issues relating to
the reliability of fMRI responses, which has obvious
importance for longitudinal studies. In general such
studies have suggested that, in healthy controls at
least, although there may be variability in the volume
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of response, there are consistent patterns of activation
between scanning sessions at the group level (Casey
et al. 1998 ; Machielsen et al. 2000 ; Chee et al. 2003).
Functional imaging techniques are therefore of interest
in the investigation of longitudinal changes related to
schizophrenia in those at high risk of developing the
disorder. It should be noted, however, that there are as
yet relatively few reproducibility studies in patient
populations (Manoach et al. 2001 ; Chen & Small, 2007)
and it is therefore important that reliability of fMRI in
such populations is addresed.
The current study examines subjects from the
Edinburgh High Risk Study (EHRS). This was a
prospective 10-year longitudinal study designed to
address issues relating to genetic vulnerability to psy-
chosis (Johnstone et al. 2002, 2005). Functional imaging
was introduced in the last 5 years of the study and
involved a sentence completion paradigm known to
activate regions reported to be abnormal in established
schizophrenia (frontal and temporal lobes). The aim of
the current study was to address three issues : (i) the
reliability of the Hayling task in high-risk and control
subjects ; (ii) whether longitudinal changes occur in
high-risk subjects who differ from healthy control sub-
jects reflecting inheritance of the schizophrenic ‘ trait ’ ;
(iii) whether longitudinal changes occur in high-risk
subjects relating to fluctuations in psychotic symp-
toms, reflecting ‘state ’-related effects. Since the study
involved high-risk participants who did not meet di-
agnostic criteria for a psychiatric disorder, the term
‘state ’ here is used to describe partial phenotypic
expression of some of the characteristic symptoms of
schizophrenia, rather than full phenotypic expression
of the disease.
Based on previous cross-sectional functional im-
aging studies relating to positive psychotic symptoms
(Cleghorn et al. 1992; Suzuki et al. 1993 ; David et al.
1996 ; Dierks et al. 1999 ; Lennox et al. 2000; Shergill
et al. 2000 ; Stephane et al. 2000; van de Ven et al. 2005),
and longitudinal structural imaging studies regarding
the importance of temporal lobe changes in early
schizophrenia (Kasai et al. 2003a, b ; Whitford et al.
2006) and high-risk subjects (Thompson et al. 2001 ;
Lawrie et al. 2002 ; Pantelis et al. 2003 ; Job et al. 2005),
and in our own cross-sectional fMRI study in high-
risk subjects (Whalley et al. 2007), we hypothesized
changes in temporal lobe activation in high-risk sub-
jects relating to changes in symptomatic state.
Method
Subject details
The EHRS examines young adults at enhanced genetic
risk of schizophrenia over the period at which they are
at greatest risk of becoming ill (Hafner et al. 1993) in
comparison with matched healthy controls (Johnstone
et al. 2002). The high-risk and control subjects were
matched as closely as possible at recruitment for age,
gender and social class at birth based on father’s oc-
cupation (see Byrne et al. 1999). High-risk participants
were selected on the basis of being aged between 16
and 25 years when first recruited (1994–1999), and
having one first- or second-degree relative with
schizophrenia and a minimum of one further genetic
relative with the illness (Hodges et al. 1999 ; Johnstone
et al. 2002, 2005). This report concerns longitudinal
fMRI data obtained during the second phase of the
study (1999–2004) when functional imaging was in-
troduced into the protocol. All subjects were supplied
with detailed written information regarding the study
and provided written informed consent. The study
was approved by the Psychiatry and Clinical Psy-
chology subcommittee of the Lothian research ethics
committee.
During the study, a total of 96 high-risk subjects and
26 matched healthy controls underwent an fMRI scan
at baseline. Sixty-three high-risk subjects and 19 con-
trol participants provided a repeat scan after approxi-
mately 18 months. Regarding the high-risk group,
33 subjects (comprising 19 asymptomatic and 14 symp-
tomatic subjects at baseline) did not have a repeat
scan: 10 refused or had withdrawn, seven were ex-
cluded because of abnormality or movement artefact,
two had become ill between assessments, for six sub-
jects it was not possible to schedule a suitable time for
assessment, and finally due to rolling recruitment a
suitable time interval between assessments had not
elapsed in eight subjects. For the controls, out of the
seven subjects who did not have a repeat scan, two
refused or had withdrawn, and three subjects were not
re-scanned due to rolling recruitment. The remainder
had either previously accompanied a participant who
had subsequently refused or withdrawn from the
study, or it was not possible to schedule a suitable time
for assessment.
Participant demographics are presented in Table 1.
At the time of scanning all subjects underwent a
structured psychiatric interview, the Present State
Examination (PSE; Wing et al. 1974). These interviews,
conducted by experienced psychiatrists (E.C.J. and
D.G.C.O.), were filmed, and videotapes have been re-
tained. The PSE was chosen as the primary method to
determine the presence or absence of psychotic
symptoms in this study as it is a detailed instrument
providing a standardized assessment of a wide range
of symptomatology, which we considered useful in
the context of establishing the extent of psychopath-
ology in the high-risk and control subjects (Johnstone
et al. 2000). Subjects were then split according to the
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presence or absence of psychotic symptoms. Our no-
tation of symptomatic or asymptomatic participants
refers specifically to the presence of isolated and/or
transient psychotic symptoms reported at interview.
Thirty-two high-risk subjects were found to be
asymptomatic at both time points (HRNN), nine sub-
jects went from asymptomatic to symptomatic (HRNP),
fifteen went from symptomatic to asymptomatic
(HRPN), five subjects were symptomatic at both time
points (HRPP), and finally two subjects went from be-
ing symptomatic to developing schizophrenia. The
diagnosis was made when psychotic symptoms were
sufficiently severe or sustained to satisfy categori-
zation in terms of PSE/Catego (Wing et al. 1974) and
ICD-10 (WHO, 1993) criteria as previously described
(Johnstone et al. 2005). Due to this small number it was
not possible to examine progressive changes preced-
ing illness. Regarding the control subjects, sixteen
subjects were asymptomatic at both time points (CNN),
and three subjects went from asymptomatic to symp-
tomatic. Analysis of demographic variables and be-
havioural measures was conducted in the Statistical
Package for the Social Sciences (SPSS version 14; SPSS
Inc., Chicago, IL, USA). There were no significant dif-
ferences in age, gender, handedness or symptomatic
status between those who were rescanned and those
that were not. Due to small numbers of subjects in the
groups containing high-risk subjects who went from
being symptomatic to ill (n=2), and control subjects
who went from being asymptomatic to symptomatic
(n=3), subsequent analyses were conducted exclud-
ing these groups.
For the purposes of the trait contrast, group com-
parisons were conducted between the control and
high-risk groups. For the purposes of the state
contrast, group comparisons were conducted between
the HRNN and the HRNP groups and between the
HRNN and the HRPN groups.
Scanning procedure
Imaging was carried out at the Brain Imaging Research
Centre (BIRC) for Scotland on a GE 1.5 T Signa scanner
(GE Medical, Milwaukee, WI, USA). The imaging
protocol consisted of a localizer scan, followed by a
T2-weighted fast spin-echo sequence, and a structural
T1-weighted sequence followed by the functional
imaging paradigms. Axial gradient-echo planar im-
ages (EPI) [repetition time 4000 ms, echo time 40 ms;
matrix=64r128; field of view (FOV) 220r440 mm]
were acquired continually. Thirty-eight contiguous
5 mm slices aligned to the anterior and posterior com-
missure were acquired within each repetition time
period. Each acquisition was run for 204 volumes, of
which the first four volumes were discarded.
Experimental paradigm
Participants performed the verbal initiation section of
the Hayling sentence completion test in the scanner
as described previously (Burgess & Shallice, 1997 ;
Whalley et al. 2004). Subjects were shown sentences
with the last word missing and were asked to silently
think of an appropriate word to complete the sentence
and press a button when they had done so, generating
within-scanner reaction time measures. Sentences
were presented in blocks of fixed difficulty, determined
by the range of suitable words suggested by the sen-
tence context, of which there were four levels. Each
block lasted 40 s and included eight sentences.












Mean age at first functional
scan, years (S.D.)
26.1 (2.2) 27.5 (2.4) 25.0 (2.6) 25.4 (3.3) 27.3 (2.8)
Gender, n
Male 10 17 3 6 2
Female 5 15 6 9 3
Time interval, years
Mean (S.D.) 1.6 (0.6) 1.5 (0.6) 1.6 (0.3) 1.3 (0.3) 1.3 (0.3)
Range 1.0–3.7 0.9–3.4 0.9–2.0 0.7–1.8 0.9–1.6
CNN, Control subjects with no psychotic symptoms at times 1 and 2 ; HRNN,
high-risk subjects with no psychotic symptoms at times 1 and 2 ; HRNP, high-risk
subjects with no psychotic symptoms at time 1 but with psychotic symptoms at time
2 ; HRPN, high-risk subjects with psychotic symptoms at time 1 but with none at
time 2 ; HRPP, high-risk subjects with psychotic symptoms at both time 1 and time 2.
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by a fixation cross for 2 s and subjects could respond at
any time until the next sentence appeared. The baseline
condition consisted of viewing a screen of white circles
on a black background for 40 s. The order of the blocks
was pseudo-random, and each blockwas repeated four
times. Immediately after scanning, subjects were given
the same sequence of sentences on paper and requested
to complete each sentence with the word they first
thought of in the scanner. ‘Word appropriateness ’
scoreswere determined from theword frequency list of
sentence completion norms (Bloom & Fischler, 1980).
For more detail, see Whalley et al. (2004).
Image processing and analysis
Scan analysis was performed using the standard
Statistical Parametric Mapping (SPM) approach in
SPM2 (The Wellcome Department of Cognitive
Neurology and collaborators, Institute of Neurology,
London; http://www.fil.ion.ucl.ac.uk/spm/) running
in MATLAB (MathWorks, Natick, MA, USA). Briefly, for
both scanning sessions EPI volumes were realigned to
the mean volume in the series, normalized to a study-
specific EPI template (comprising 121 participants of
the EHRS) and spatially smoothedwith a 6r6r6 mm3
full-width half-maximum (FWHM) Gaussian filter.
First-level analysis
Statistical analysis was performed using the general
linear model approach as implemented in SPM. At the
individual subject level the data were modelled with
five conditions (the four difficulty levels and baseline),
each modelled by a boxcar function convolved with a
synthetic haemodynamic response function. Estimates
of head movement from the realignment stage of pre-
processing were included as additional regressors in
the analysis. Before fitting the model the first-order
autoregressive (AR-1) technique was used to address
issues of temporal autocorrelations in the data and the
data were filtered in the time domain using a high-
pass filter (200 s cut-off). Contrasts were constructed
to examine all four sentence completion conditions
versus baseline, and a parametric contrast which exam-
ines increasing activation with increasing difficulty
(Whalley et al. 2004).
Second-level analysis
Contrast images for each subject representing a
subject-specific summary of brain responses to the
different conditions were then entered into second-
level random-effects analyses. Initially, a single-
sample t test was used to generate within-group maps
for each time point for both sentence completion versus
baseline and the parametric contrast. Within-subject
‘change’ maps were then generated for sentence
completion versus baseline and the parametric contrast
by subtracting for each subject the respective contrast
images from visit 1 from visit 2, divided by the time
interval between the scanning sessions. Although
there were no significant group differences in the time
interval between the scans, the time interval was in-
cluded to control for within-subject variability related
to the between-scan interval. The individual subject
change maps were then entered into further random-
effects analyses to examine changes in activation
within (one-sample t test) and between (analysis of
variance ; ANOVA) each of the groups. To test the
concurrent validity of this approach, results from the
active versus baseline contrast were compared with a
more complex repeated-measures analysis of covari-
ance (ANCOVA) model. Here, contrast images for
each individual from time 1 and time 2 were entered
as separate regressors into the model (per group) and
the time interval between the scans was entered as a
covariate of no interest. Contrasts were then con-
structed to examine activation differences between the
groups. The two approaches yielded a similar pattern
of results ; therefore, the simpler ‘one contrast image
per subject ’ subtraction model was used.
Statistical maps were thresholded at a level of
p=0.001 uncorrected, and regions were considered
significant at p<0.05 cluster level-corrected for mul-
tiple comparisons. All p values quoted in the text are at
the corrected cluster level. A small volume correction
for the temporal lobes was applied to contrasts exam-
ining state effects in line with our a priori hypothesis
of change in activation in this region with symptom
development.
Reliability measures
Reliability was assessed using approaches similar to
those described previously (Specht et al. 2003 ; Aron
et al. 2006). Measures were computed for the CNN and
HRNN groups only in order that reliability measures
were not confounded by symptom effects seen in the
other groups. Intra-class correlation coefficient (ICC)
values were calculated on a voxel-by-voxel basis using
a one-way ANOVA model (Specht et al. 2003) on con-
trast images representing sentence completion versus
baseline. High ICC values suggest low within-subject
variability. The resulting three-dimensional ICC maps
of ICC values >0.5 were then masked with a binary
image representing the main network of regions in-
volved in the task at visit 1 or visit 2 (Aron et al. 2006).
The mask was generated by performing a one-sample
t test on subjects at visit 1 and at visit 2. The resulting
group activation maps for visit 1 and visit 2 were then
thresholded at p=0.01 [p corrected family-wise error
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(FWE), cluster extent threshold in voxels (KE)=500],
and a binary mask created. ICC maps therefore only
present voxels that were activated at visit 1 or at visit 2.
Themean response for threemain regions of interest
(left superior/medial frontal gyrus, left middle tem-
poral gyrus and left inferior frontal gyrus) for each
subject and each visit was also extracted in order to
generate signal plots of visit 1 versus visit 2. The co-
ordinates for the three main regions of interest were
identified from the cluster results from an all-subjects
second-level random-effects analysis ; the left su-
perior/middle frontal gyrus (x4, 4, 56), the left middle
temporal gyrus (x54, x38, x6) and the left inferior
frontal gyrus (x54, 14, 14) and values were extracted




There were no statistically significant differences be-
tween the groups regarding the time interval between
the scans, or gender. There was, however, a significant
difference in age at the time of the first functional scan
between the groups (p=0.049). The results presented
below survived controlling for age. Behavioural
measures for each time point are presented in Table 2.
These indicated the expected pattern of quicker reac-
tion time and lower word appropriateness scores with
greater contextual constraint at both assessments and
indicate that the subjects were performing the task
appropriately in the scanner. There were no significant
grouprtime interactions for any of the behavioural
measures (general linear model repeated-measures
ANCOVA).
Reliability measures
Fig. 1 presents within-group maps at each time point
for sentence completion versus baseline, providing a
means of qualitative assessment of reliability. Fig. 1
shows that there were consistent activation patterns
across time in both groups in regions previously as-
sociated with the task, namely the left precentral
gyrus, inferior frontal gyrus, medial/superior frontal
Table 2. Behavioural measuresa
CNN HRNN HRNP HRPN HRPP
Word appropriateness score visit 1
Low 6.3 (1.4) 6.4 (0.8) 5.9 (1.3) 6.4 (1.0) 6.4 (0.6)
Medium low 3.1 (0.5) 3.2 (0.6) 3.3 (0.5) 3.4 (0.6) 3.3 (0.5)
Medium high 1.8 (0.3) 2.0 (0.4) 1.8 (0.3) 2.0 (0.4) 2.0 (0.3)
High 1.1 (0.7) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1)
Word appropriateness score visit 2
Low 6.0 (1.0) 6.0 (1.0) 6.5 (1.0) 6.2 (1.0) 6.7 (0.5)
Medium low 3.0 (0.4) 3.1 (0.6) 3.0 (0.5) 3.2 (0.6) 3.1 (0.4)
Medium high 1.9 (0.3) 1.8 (0.3) 1.8 (0.3) 1.9 (0.3) 2.0 (0.2)
High 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1)
Reaction time visit 1, ms
Low 2613 (440) 2586 (581) 2163 (433) 2723 (795) 2635 (597)
Medium low 2479 (540) 2488 (642) 2022 (474) 2652 (811) 2490 (599)
Medium high 2357 (560) 2360 (655) 1847 (389) 2491 (837) 2469 (745)
High 2291 (589) 2357 (666) 1846 (446) 2493 (820) 2373 (667)
Reaction time visit 2, ms
Low 2681 (684) 2505 (603) 2060 (502) 2829 (706) 2323 (363)
Medium low 2610 (735) 2449 (615) 2051 (437) 2673 (406) 2244 (378)
Medium high 2535 (770) 2306 (630) 1941 (450) 2574 (746) 2088 (419)
High 2448 (758) 2310 (593) 1919 (430) 2565 (718) 2119 (448)
CNN, Control subjects with no psychotic symptoms at times 1 and 2 ; HRNN, high-risk subjects with no psychotic symptoms
at times 1 and 2 ; HRNP, high-risk subjects with no psychotic symptoms at time 1 but with psychotic symptoms at time 2 ;
HRPN, high-risk subjects with psychotic symptoms at time 1 but with none at time 2 ; HRPP, high-risk subjects with psychotic
symptoms at both time 1 and time 2.
Values are given as mean (standard deviation).
a Constraint levels high to low represent increasing task difficulty. Low word appropriateness scores represent more
appropriate words, i.e. better task performance. Reaction times were recorded in the scanner.
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gyrus, middle temporal gyrus, and the right posterior
lobe of the cerebellum.
ICC maps for the main regions activated for the
sentence completion versus baseline contrast are pre-
sented in Fig. 2(a, b) for both groups for voxels acti-
vated at either visit 1 or visit 2. Plots of the mean
response in these regions for visits 1 and 2 are pre-
sented in Fig. 2c and indicate that responses were
highly correlated and were similar across the groups.
ICC values for the mean responses for the three main
regions of interest are presented in Table 3. Values
ranged from 0.55 to 0.65 for the controls and from 0.65
to 0.80 for the HRNN group, indicating good agree-
ment.
Sentence completion versus baseline contrast
Trait effects
Formal statistical comparisons revealed no significant
differences between the groups at the chosen levels of
significance.
State effects
Comparison of the HRNN and HRNP groups revealed
significant increases in activation over time in those
at high risk who moved from asymptomatic to symp-
tomatic in the left middle temporal gyrus (BA21)
[pcorrected=0.026, KE=112, Z=3.94 (–64, –38, –6)],
using a small volume correction for temporal lobes
(Fig. 3). There were no significant differences between
the HRNN and HRPN groups.
Parametric contrast
Trait effects
Formal comparison of the changes over time between
the groups revealed no significant differences between
the groups at the chosen levels of significance.
State effects
Comparison of the HRNN and HRNP, and HRNN and
HRPN groups revealed no significant increases or de-
creases over time between the groups.
Visit 1 Visit 2
(a)
(b)
Fig. 1. Sentence completion versus baseline maps (a) for control subjects (n=16) at visits 1 and 2, thresholded at T=3.5, cluster
extent threshold in voxels (KE)=100, and (b) maps for high-risk subjects (n=61) for visits 1 and 2, thresholded at T=5.5,
KE=100. Maps were thresholded at different levels for visualization purposes only in order to accommodate differences in
group numbers. Standard statistical thresholds were used in all group comparisons.
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(c)
Fig. 2. Intra-class correlation coefficient values (<0.5) are shown for the main regions of activation in the sentence completion
versus baseline contrast for (a) control subjects with no psychotic symptoms at times 1 and 2 (CNN group) and (b) high-risk
subjects with no psychotic symptoms at times 1 and 2 (HRNN group) ; see Method section for further details. (c) Signal plots are
presented for the three main regions of interest at visit 1 and visit 2 for the CNN (#) and HRNN (’) groups. The three main
regions of interest are the superior/medial frontal gyrus (S/MFG), the middle temporal gyrus (MTG) and the inferior frontal
gyrus (IFG).
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Discussion
The results of this large longitudinal fMRI study con-
ducted over a relatively long time interval (18 months)
indicate no change over time between high-risk
subjects and controls (‘ trait ’ effects). We did, however,
see changes over time in those developing psy-
chotic symptoms. Our results, therefore, indicate that
the greatest functional changes over time in our
high-risk subjects relate to changes in (sub-diagnostic)
symptoms, i.e. ‘ state ’ effects. Behavioural measures
indicated minimal practice effects and all those stud-
ied were naive to antipsychotic medication – hence the
findings are unlikely to be attributable to such factors.
Furthermore, reliability measures indicated consistent
patterns of activation in the stable asymptomatic
groups.
The small number of functional longitudinal studies
on the established illness have in general been con-
ducted with the purpose of examining effects of
medication on changes in symptoms and brain func-
tion (Davis et al. 2005). In general, these studies sug-
gest treatment effects or ‘normalization’ of brain
function in frontal, temporal and cerebellar regions
post-medication (Honey et al. 1999 ; Davis et al. 2005 ;
Stip et al. 2005 ; Yurgelun-Todd et al. 2005). By design,
however, these studies have been conducted over rela-
tively short time-frames and do not address longer-
term changes in function and symptoms over the
course of the illness. These studies have also been ac-
companied by methodological limitations such as
small sample sizes, lack of healthy control data, and a
lack of reliability measures (Davis et al. 2005). As de-
scribed earlier, the majority of reproducibility studies
have been conducted on healthy control populations,
and very few studies have examined reproducibility
in patient populations, particularly using complex
tasks (Manoach et al. 2001 ; Chen & Small, 2007). Our
reproducibility findings in both controls and high-risk
subjects performing the current cognitive task in-
dicating good agreement aid interpretation of the
current findings and are encouraging for future
longitudinal fMRI studies.
In line with our original hypothesis regarding pro-
gressive changes in the temporal lobe, fluctuating
symptom effects were associated with changes in ac-
tivation in the lateral temporal cortex. High-risk sub-
jects who moved from asymptomatic to symptomatic
demonstrated increasing activation in the left middle
temporal gyrus. Although to our knowledge there are
no other longitudinal fMRI studies in high-risk in-
dividuals, our findings are in general consistent with
the available literature regarding progressive struc-
tural changes in grey matter in the lateral temporal
cortex during early stages of the illness (Kasai et al.
2003a, b ; Whitford et al. 2006) and in high-risk in-
dividuals (Thompson et al. 2001 ; Lawrie et al. 2002 ;
Pantelis et al. 2003 ; Job et al. 2005). Indeed, the lateral
temporal cortex has been widely implicated regarding
the manifestation of psychotic symptoms in the es-
tablished illness, in particular auditory hallucinations
(Cleghorn et al. 1992 ; Suzuki et al. 1993 ; David et al.
1996 ; Dierks et al. 1999 ; Lennox et al. 2000 ; Shergill
et al. 2000 ; Stephane et al. 2000 ; van de Ven et al. 2005).







gyrus (–4, 4, 56)
0.65 0.80
Left middle temporal gyrus
(–54, –38, –8)
0.55 0.68
Left inferior frontal gyrus
(–54, 14, 14)
0.60 0.65
ICC, Intra-class correlation coefficient ; CNN, control
subjects with no psychotic symptoms at times 1 and 2 ;
HRNN, high-risk subjects with no psychotic symptoms at
times 1 and 2.







Fig. 3. State contrast : significant difference between high-risk
groups in the left posterior middle temporal gyrus (p=0.026),
representing greater increases over time in the high-risk
subjects with no psychotic symptoms at time 1 but with
psychotic symptoms at time 2 (HRNP group) versus the
high-risk subjects with no psychotic symptoms at times
1 and 2 (HRNN group).
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Further, although slightly more anterior to the region
reported here, we have also prevously found associ-
ations between activation in the left middle temporal
gyrus and the severity of hallucinations in the full
baseline sample of the same high-risk cohort (Whalley
et al. 2007). Due to the relatively small numbers of
high-risk subjects in the asymptomatic to symptomatic
group, however, we did not consider it appropriate in
the current study to further split the group according
to the types of symptoms experienced. It is also worth
noting that the current results were seen for the con-
trast of sentence completion (all levels of difficulty)
versus a visual baseline, rather than the more subtle
and more heavily controlled parametric contrast. We
cannot exclude the possibility therefore that these
findings may relate to basic cognitive processes in-
volved in the task rather than higher-level processes
relating specifically to semantic memory components
of the task.
One other limitation of the current study is that
the group of subjects with fluctuating symptoms is
relatively small. The difficulty in collecting such data,
however, should not be underestimated. We also ac-
knowledge that the finding of increasing activation
when subjects move to being symptomatic would
be strengthened if the reverse were seen in those
moving to being asymptomatic. It is difficult to
speculate why this was not the case since little is
known regarding the course and fluctuation of psy-
chotic symptoms, and indeed it may simply be the
case that in clinical terms the HRNP group are not
simply the ‘ inverse’ of the HRPN group. Another
methodological issue relates to the chosen group
comparisons. Although a number of other compari-
sons were possible we considered that a restricted
range of comparisons of specific groups directed at
addressing our primary hypotheses was the most
favourable approach in order to limit the number of
comparisons made. It is also worth noting that it is not
possible to say from these data whether these func-
tional brain changes represent the cause or conse-
quence of the symptomatic changes.
In conclusion, findings from this study indicate that
fMRI activation patterns were consistent in the clini-
cally stable groups of controls and genetic high-risk
subjects. Further, they demonstrate the presence
of symptom-related functional brain changes in sub-
jects at high genetic risk of schizophrenia, indicating
changes in functional activation occur in association
with the development of psychotic symptoms. These
findings are consistent with other literature indicat-
ing that changes in symptomatology and neurobi-
ology are an important aspect in our improved
understanding of the neural changes underpinning
schizophrenia.
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